{"id":205933,"name":"ACCURAY","slug":"accuray","state":"CA","country":"United States of America","description":"Manufacturing and Developing Precision Radiation Technologies","totalSpending":220000,"filings":19,"yearlySpending":[{"year":2020,"income":80000},{"year":2021,"income":110000},{"year":2022,"income":30000},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"TAR","display":"Tariff (miscellaneous tariff bills)"}],"firms":["BURT ROSEN STRATEGIES"],"lobbyists":["BURT ROSEN"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Defense, Dept of (DOD)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to furthering knowledge of Radiation Oncology and precision radiation.\nCOVID Relief relating to developing companies.","Covid Relief Dealing with restart and tax credits","Covid Relief Dealing with restart and tax credits","Tax Credits for R&D and NOL under Covid Relief","Covid Relief Dealing with restart and tax credits"]}